Founded in February 2014, Perlara is a decentralized biotech company focused on rare disease drug discovery. Its core mission is to empower rare disease families, companies, and impact investors to find treatments and cures through collaborative R&D ventures known as PerlQuests. Perlara offers services like Guided Cures™ and Cure Odysseys™, which involve top researchers and clinicians guiding families through the complex process of developing treatment paths. The company aims to create a predictive R&D engine, ArkBase, to facilitate drug repurposing and clinical development.
Perlara has collaborated with numerous rare disease families and has been supported by various impact investors. Notable figures affiliated with Perlara include its founder, Ethan Perlstein, who has been instrumental in driving the company's vision. Key achievements include the successful launch of multiple PerlQuests and the development of ArkBase. Perlara's impact lies in its innovative approach to rare disease research, offering hope and tangible progress for families affected by these conditions.
